Structural basis for a potent neutralising single-domain antibody that blocks SARS-CoV-2 binding to its receptor ACE2
Huo, J., Le Bas, A., Ruza, R.R., Duyvesteyn, H.M.E., Mikolajek, H., Malinauskas, T., Tan, T., Rijal, P., Dumoux, M., Ward, P.N., Ren, J., Zhou, D., Harrison, P.J., Radecke, J., Zhao, Y., Jaramillo, J.G., Knight, M., Carrique, L., Shah, P., James, W., Townsend, A., Stuart, D.I., Owens, R.J., Naismith, J.H.To be published.